睡眠障害治療：世界市場の展望

当レポートでは、世界の睡眠障害治療の市場を調査し、疾患・治療の概要、市場成長への各種影響因子の分析、技術スナップショット、市場規模の推移・予測、各種区分・地域別の詳細分析、主要企業のプロファイルなどをまとめています。

目次

第1章 市場の見通し

• 市場のスナップショット

第2章 エグゼクティブサマリー

第3章 市場概要

• 概要
• さまざまなタイプの睡眠障害
  • 不眠症
  • 睡眠時無呼吸
  • いびき
  • 睡眠麻痺
  • 寝言
  • ナルコレプシー
  • 睡眠障害の治療
• 睡眠障害治療の未来
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場の課題
• 睡眠障害治療市場のマクロ経済要因
  • COVID-19の影響
  • ロシア・ウクライナ戦争の影響

第4章 市場機会・技術スナップショット

• 市場機会
• 睡眠の調節
• さまざまな流通チャネル
  • オンライン薬局
  • オフライン薬局
• 製品タイプ
  • ブランド薬
  • ジェネリック薬

第5章 市場内訳：薬剤/製品タイプ別

• 薬剤タイプ別
  • ベンゾジアゼピン
  • 非ベンゾジアゼピン
  • 抗うつ薬
  • メラトニン拮抗薬
  • その他
• 製品タイプ別
  • 市販薬（OTC）
  • 処方薬
  • ハーブベース薬剤

第6章 市場内訳：地域別

• 概要
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第7章 企業プロファイル

• AZURITY PHARACEUTICALS INC.
• HIKMA PHARMACEUTICALS PLC
• IDORSIA PHARMACEUTICALS LTD.
• JAZZ PHARMACEUTICALS PLC
• MERCK & CO. INC.
• PFIZER INC.
• SANOFI S.A.
• VANDA PHARMACEUTICALS
• VIATRIS INC.
• ZYDUS CADILA GROUP

第8章 プロジェクト範囲・調査手法

List of Tables

• Summary Table : Global Market for Sleep Disorder Treatments, by Region, Through 2027
• Table 1 : Examples of Different Drugs
• Table 2 : Examples of Different Drugs
• Table 3 : Global Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
• Table 4 : Global Market for Sleep Disorder Treatments, by Type of Product, Through 2027
• Table 5 : Global Market for Sleep Disorder Treatments, by Region, Through 2027
• Table 6 : North American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
• Table 7 : North American Market for Sleep Disorder Treatments, by Type of Product, Through 2027
• Table 8 : European Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
• Table 9 : European Market for Sleep Disorder Treatments, by Type of Product, Through 2027
• Table 10 : Asia-Pacific Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
• Table 11 : Asia-Pacific Market for Sleep Disorder Treatments, by Type of Product, Through 2027
• Table 12 : Latin American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
• Table 13 : Latin American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
• Table 14 : Middle Eastern and African Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
• Table 15 : Middle Eastern and African Market for Sleep Disorder Treatments, by Type of Product, Through 2027
• Table 16 : Azurity Pharmaceuticals Inc.: Product Offering
• Table 17 : Hikma Pharmaceuticals plc: Product Offering
• Table 18 : Idorsia Pharmaceuticals Ltd.: Product Offering
• Table 19 : Jazz Pharmaceuticals plc: Product Offering
• Table 20 : Jazz Pharmaceuticals plc: Recent Developments, 2022
• Table 21 : Merck & Co. Inc.: Product Offering
• Table 22 : Pfizer Inc.: Product Offering
• Table 23 : Sanofi S.A.: Product Offering
• Table 24 : Vanda Pharmaceuticals: Product Offering
• Table 25 : Viatris Inc.: Product Offering
• Table 26 : Zydus Cadila Group: Product Offering
• Table 27 : Zydus Cadila Group: Recent Developments, 2022

List of Figures

• Summary Figure : Global Market Shares of Sleep Disorder Treatments, by Region, 2021
• Figure 1 : Different Types of Sleep Disorders
• Figure 2 : Different Types of Treatment for Sleep Disorders
• Figure 3 : Global Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
• Figure 4 : Global Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
• Figure 5 : Global Market Shares of Sleep Disorder Treatments, by Region, 2021
• Figure 6 : Rate of Insomnia in Regions of the the U.S., 2022
• Figure 7 : North American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
• Figure 8 : North American Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
• Figure 9 : Prevalence of Anxiety, Depression, and Stress in Selected European Countries, 2022
• Figure 10 : European Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
• Figure 11 : European Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
• Figure 12 : Top 10 Countries with Highest Number of Citizens Aged Above 65, Asia-Pacific, 2022
• Figure 13 : Number of People with Diabetes, Asia-Pacific, by Country, 2022
• Figure 14 : Asia-Pacific Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
• Figure 15 : Asia-Pacific Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
• Figure 16 : Latin American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
• Figure 17 : Latin American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
• Figure 18 : Middle Eastern and African Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
• Figure 19 : Middle Eastern and African Market Shares of Sleep Disorder Treatments, by Type of Product, 2021

Highlights:

The report provides an overview of the global sleep disorders treatment market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. It covers the market for sleep disorders treatment across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape.

Report Scope:

In this report, the market has been segmented based on product type, medication type, and geography. The report provides an overview of the global sleep disorders treatment market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. The scope of the report includes pharmaceutical sales and anxiolytic consumption, as well as hypnotics and sedative consumption, non-mental health related disorders, and all other types of medications that aid in improving sleep quality.

The report covers the market for sleep disorders treatment across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for Sleep Disorder Treatments in 2021 and provides projections for the expected market size through 2027.

Different types of drugs are used to treat insomnia, sleep apnea, and other sleep disorder problems. Additionally, the report discusses the different medication types used to treat sleep disorders. This report does not include any therapeutic devices used for treating patients. Medications generally help induce sleep by inhibiting central nervous system activity. Sleeping tablets are routinely used to treat insomnia. The impact of sleep drugs depends on their chemical composition. The growing product approval for sleep drugs is another reason for conducting this market study.

Report Includes:

• 14 data tables and 14 additional tables
• An updated overview and in-depth analysis of the global market for global sleep disorder treatment
• Analyses of the global market trends, with historic market revenue data for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
• Discussion of industry growth driving factors and major technology issues and challenges affecting the market for sleep disorders treatment as a basis for projecting demand over the next few years (2022-2027)
• Estimation of the actual market size and revenue forecast for global sleep disorder treatment market in USD million values, and corresponding market share analysis by product type, drug type, and region
• A comparative study and Porter's Five Forces analysis considering both the micro and macro environmental factors prevailing in the sleep disorder treatment market
• Holistic review of the impact of the COVID-19 pandemic and the Russia-Ukraine war on the global sleep disorders treatment markets
• Coverage of the technological, economic, and business considerations of the global sleep disorder treatment market, with market data analyses and growth forecasts through 2027
• Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
• Company profiles of major players within the industry, including Jazz Pharmaceuticals plc, Pfizer Inc., Sanofi S.A., and Zydus Cadila Group

Table of Contents

Chapter 1 Market Outlook

• 1.1 Market Snapshot

Chapter 2 Executive Summary

Chapter 3 Market Overview

• 3.1 Overview
• 3.2 Different Types of Sleep Disorders
  • 3.2.1 Insomnia
  • 3.2.2 Sleep Apnea
  • 3.2.3 Snoring
  • 3.2.4 Sleep Paralysis
  • 3.2.5 Sleep Talking
  • 3.2.6 Narcolepsy
  • 3.2.7 Treatment for Sleep Disorders
• 3.3 Future of Sleep Disorder Treatment
• 3.4 Market Dynamics
  • 3.4.1 Market Drivers
  • 3.4.2 Market Restraints
  • 3.4.3 Market Challenges
• 3.5 Macroeconomic Factors of Market for Sleep Disorder Treatments
  • 3.5.1 Impact of COVID-19 on Market for Sleep Disorder Treatments
  • 3.5.2 Impact of Russia-Ukraine War on Market for Sleep Disorder Treatments

Chapter 4 Market Opportunities and Technology Snapshot

• 4.1 Market Opportunities
  • 4.1.1 Implementation of Artificial Intelligence in Sleep Disorders
  • 4.1.2 Growing Demand for Home Sleep Test
• 4.2 Regulation of Sleep
  • 4.2.1 Neurotransmitter Regulation
  • 4.2.2 Hypothalamic Regulation
  • 4.2.3 Pharmaceutical Regulation
• 4.3 Various Distribution Channels
  • 4.3.1 Online Pharmacy
  • 4.3.2 Offline Pharmacy
• 4.4 Type of Product
  • 4.4.1 Branded
  • 4.4.2 Generic

Chapter 5 Market Breakdown by Drug/Product Type

• 5.1 Market for Sleep Disorder Treatments by Type of Drug
  • 5.1.1 Benzodiazepines
  • 5.1.2 Nonbenzodiazepines
  • 5.1.3 Antidepressants
  • 5.1.4 Melatonin Antagonists
  • 5.1.5 Others
• 5.2 Market for Sleep Disorder Treatments by Type of Product
  • 5.2.1 Over-the-Counter (OTC) Drugs
  • 5.2.2 Prescription-Based Drugs
  • 5.2.3 Herbal-Based Drugs

Chapter 6 Market Breakdown by Region

• 6.1 Overview
• 6.2 North America
• 6.3 Europe
• 6.4 Asia-Pacific
• 6.5 Latin America
• 6.6 Middle East and Africa

Chapter 7 Company Profiles

• AZURITY PHARMACEUTICALS INC.
• HIKMA PHARMACEUTICALS PLC
• IDORSIA PHARMACEUTICALS LTD.
• JAZZ PHARMACEUTICALS PLC
• MERCK & CO. INC.
• PFIZER INC.
• SANOFI S.A.
• VANDA PHARMACEUTICALS
• VIATRIS INC.
• ZYDUS CADILA GROUP

Chapter 8 Project Scope and Methodology

• 8.1 Scope of Report
• 8.2 Methodology
• 8.3 Analyst's Credentials
• 8.4 BCC Custom Research
• 8.5 Related BCC Research Reports